Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,931 public trials 462 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Therapy Optimization in Multiple Sclerosis (MS)

NCT00819000

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +10 more
Locations
  • Teva Investigational Site Swartz Creek, Michigan, United States
  • Teva Investigational Site Columbus, Ohio, United States
  • Teva Investigational Site Carnegie, Pennsylvania, United States
View Trial Details
Completed

Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)

NCT00086671

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Site Reference ID/Investigator# 107 Phoenix, Arizona, United States
  • Site Reference ID/Investigator# 163 Sun City, Arizona, United States
  • Site Reference ID/Investigator# 156 Little Rock, Arkansas, United States
  • Site Reference ID/Investigator# 154 Irvine, California, United States
View all 44 locations
View Trial Details
Completed

Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis

NCT00134563

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Sanofi-Aventis Bridgewater, New Jersey, United States
  • Sanofi-Aventis Austria Vienna, Austria
  • sanofi-aventis, Canada Laval, Canada
  • Sanofi-Aventis Santiago, Chile
View all 21 locations
View Trial Details
Completed

Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis

NCT00811395

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Vienna, Austria
  • Sanofi-Aventis Administrative Office Laval, Canada
  • Sanofi-Aventis Administrative Office Berlin, Germany
View Trial Details

Related conditions